Examines US law and governmental policy affecting domestic and multinational pharmaceutical manufacturing. This book recommends pragmatic ways to interpret and comply with FDA CGMP regulation and related criteria, they focus on geographical redistribution of manufacturing facilities, adaptation to disparate human resources, and others.